ArticleScientific reports2025

Ifebemtinib and paclitaxel synergistically inhibit the proliferation and metastasis of TNBC by blocking PI3K/Akt pathway through LSD1/PIK3IP1 axis.

Yong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.